MedPath

Platelet Rich Plasma (PRP) as a Treatment for ACHILLES Tendon Tears

Phase 2
Completed
Conditions
Achilles Tendon Tear
Registration Number
NCT00731068
Lead Sponsor
Meir Medical Center
Brief Summary

To review the influence of patient derived PRGF on the healing process of Achilles tendon after a surgical correction of a complete tear.

Detailed Description

Autologous platelet-rich matrices may aid in post surgical patients by promoting and accelerating tissue healing because of the release of growth factors including transforming growth factor (TGF)-beta1 and platelet-derived growth factor (PDGF) from platelet alpha-granules.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • A complete tear of Achilles tendon
  • Age 18-50 years old
Exclusion Criteria
  • under 18 year of age
  • pregnancy
  • physical or mental disabilities

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
improvement of symptoms / disease progress1 year
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.